Skip to content
★ Sign in to follow
BB

Bernie B. Berry III

Executive
Director
Total declarations
23
Company
1
▲ Purchases (1 ops.)
€55k
▼ Sales (13 ops.)
€1.2M

Latest filing published 04 Nov 2021 for ORTHOPEDIATRICS CORP.

Filing timeline

BuySale
Bernie B. Berry III

Insider track record

Disclosed buys
1
Disclosed sells
13
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 13 Mar 2018 · 3163 days ago · €55k
    +138.7%
    Entry US$17.14 · Close at T+365 US$40.91

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Bernie B. Berry III: trading record in brief

This profile gathers the share dealings of Bernie B. Berry III in Orthopediatrics Corp, where the filings describe the role as senior executive. Over a trading history stretching from 16 October 2017 to 2 November 2021, the count stands at 23 filings.

Both buying and selling appear: 1 purchase worth €55k, against 13 sales worth €1.2M. Taken together, the sales exceed the purchases by €1.1M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 5 share grants and 3 option exercises. 2021 to date brings no purchases and 10 sales.

On 4 November 2021 came the latest disclosure, a share grant in Orthopediatrics Corp. The clock since the last published purchase (13 March 2018) now reads 3,163 days. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Bernie B. Berry III

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations22 total

22 of 22 declarations